Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass.
about
The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomasDiagnostic value of ultrasound indicators of neoplastic risk in preoperative differentiation of adnexal masses.Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studiesComparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.Recent advances in the biomarkers for epithelial ovarian cancer.HE4, CA-125, and cystic ovarian massDiscrepant clinicopathologic characteristics and HE4 performance in type I and type II epithelial ovarian cancer.Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers.Analysis of falsely elevated risk of ovarian malignancy algorithm in women with ovarian endometrioma.Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: A pilot study.Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.Accuracy of Pelvic Mass Score in Pre-operative Determination of Malignancy in Adnexal Masses.HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases.From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade.The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer.The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.Usefulness of the preoperative platelet count in the diagnosis of adnexal tumors.Simple laboratory score improves the preoperative diagnosis of adnexal mass.
P2860
Q26992102-62F6459C-5FF4-4424-B814-0859FCE4EEE7Q30396133-AAC423A8-D619-4BD0-9EB9-58EEFC0317ECQ30414041-15743505-AE90-4B67-A8D0-439AE90B3447Q33733786-94395CF9-1D9D-40C7-9C4E-AC70592BC37BQ34391119-6D3AA06B-A093-4D64-840B-CB10416C3750Q35663610-EAC66183-E0E1-4FEA-9E16-830994C13A07Q35663613-E85F3410-B984-4446-B088-DFCB1A48C681Q35886081-B92EF162-29C8-4878-B2DF-0346315269CCQ35925743-05CBCB02-7B45-458D-8426-D489C13556C9Q36556482-01F6860D-2234-4C13-A6DA-4FF0158CB462Q37121126-0A71A93A-3FB5-4D8B-B4B3-991DE2692F8AQ37200036-1CE67C69-F669-4CAB-9627-1DFCE7E14809Q37406838-E7538B95-EBED-47AD-9BFB-241E6D8527A4Q37543205-BC52C5CC-00BB-4081-A9CB-0AFCF7C48C05Q37611329-0FE1DD10-AE67-4475-879F-BD7BD9CBD65BQ38052927-80C27C16-DDE7-481D-9E4F-BBE86DE2AD30Q38388103-CE69087B-5AF0-4C1A-9B39-FFAD5FC88DF5Q38653169-7FC4E9E1-6E6E-435F-A5AD-C542539F448EQ39748368-E4D594D8-F47A-44BB-A8D6-D529108AE64CQ53300581-E38ED527-D4D0-4C12-A2AE-303A9E7750AF
P2860
Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Evaluation of ovarian cancer b ...... uspicious cystic ovarian mass.
@ast
Evaluation of ovarian cancer b ...... uspicious cystic ovarian mass.
@en
type
label
Evaluation of ovarian cancer b ...... uspicious cystic ovarian mass.
@ast
Evaluation of ovarian cancer b ...... uspicious cystic ovarian mass.
@en
prefLabel
Evaluation of ovarian cancer b ...... uspicious cystic ovarian mass.
@ast
Evaluation of ovarian cancer b ...... uspicious cystic ovarian mass.
@en
P2093
P2860
P1476
Evaluation of ovarian cancer b ...... uspicious cystic ovarian mass.
@en
P2093
Björg Kristjansdottir
Karin Sundfeldt
Karolina Partheen
P2860
P304
P356
10.3802/JGO.2011.22.4.244
P577
2011-12-05T00:00:00Z